Corporate Roundup

12/15/2014


Kroger ($61; KR) has pulled another profit surprise out of its cart. October-quarter per-share profits jumped 30% to $0.69 excluding special items, topping the consensus by $0.08, helped by unusually high profit margins on fuel sales. Revenue advanced 11%, also ahead of expectations. Excluding fuel, same-store sales rose 5.6%, the 44th consecutive quarter of growth. Kroger boosted its profit guidance for the year ending January. The company expects same-store sales excluding fuel to climb 4% to 5% in the January quarter. Shares rallied on the report. Kroger is a Focus List Buy and a Long-Term Buy.


Shire ($208; SHPG) said its pipeline, which includes potential treatments for diseases such as cystic fibrosis, should generate $3 billion in product sales by 2020. The drugmaker reported product sales of $5.61 billion in the 12 months ended September, and most of its current drugs are still growing sales at double-digit rates. Shire is a Focus List Buy and a Long-Term Buy.


Current Hotline

Stock Spotlight

Individual Stock Reports

ISRs make stock research easy!

Perhaps the most valuable two page reports available anywhere.

All the data you would normally have to plow through years of 10-K filings, earnings reports, and reams of market data to assemble — yours all in one concise report.

ISRs contain our proprietary Quadrix scores — find out how we rate all the stocks in the S&P 500.

Visit us at individualstockreports.com